On Tuesday, China heightened its trade tensions with the U.S. by banning Illumina, a leading biotechnology firm, from importing gene-mapping products. This comes in retaliation for U.S. tariffs, with China also targeting 15 other American companies for punitive measures. The actions exemplify Beijing's use of blacklists as a strategic tool in the ongoing trade war, extending previous measures that had focused primarily on defense-related firms. This broadening of targets highlights the increasing severity and complexity of the trade conflict between the two nations.
China has escalated its trade measures by banning Illumina, a key American biotech firm, from importing its products in response to U.S. tariffs.
The punitive actions against numerous companies demonstrate Beijing's strategy of using blacklists as a means of retaliating against Washington during the trade war.
Collection
[
|
...
]